NRC/SECY/RAS
From kanterella
Jump to navigation
Jump to search
(NRC/SECY/RAS) | |
|---|---|
| HQ Office | |
| HQ Division |
NRR
Division of Licensing Projects
Japan Lessons-Learned Division Division of Policy and Rulemaking
Division of Inspection and Regional Support
Division of Materials and License Renewal Division of Operating Reactor Licensing
No value Acquisition Management Division Division of Administrative Services Office of Nuclear Reactor Regulation
Division of Licensing Projects Japan Lessons-Learned Division No value Division of Policy and Rulemaking Division of Inspection and Regional Support Division of Materials and License Renewal Division of Operating Reactor Licensing Division of Regulatory Improvement Programs Division of Systems Safety and Analysis
No value Division of Construction Inspection and Operational Programs Office of Nuclear Material Safety and Safeguards
No value Division of Fuel Cycle Safety, Safeguards, and Environmental Review Division of Spent Fuel Management Division of Decommissioning, Uranium Recovery and Waste Programs Office of Nuclear Regulatory Research
No value Division of Engineering Technology Office of Nuclear Security and Incident Response
No value Division of Security Operations
No value Governance & Enterprise Management Services Division
No value
No value
No value
No value
No value Office of the Chief Human Capital Officer
No value
No value
No value
No value
No value Office of Information Services
No value
No value
No value
Office of Public Affairs Region I Office of Public Affairs Region II The following 2 query conditions could not be considered due to this wiki's restrictions on query size or depth: <code> [[:Advisory Committee on the Medical Uses of Isotopes]] OR [[:Atomic Safety and Licensing Board Panel]] OR [[:Document Control Desk]] OR [[:Embark Venture Studio]] OR [[:NRC/ACRS]] OR [[:NRC/ASLBP]] OR [[:NRC/Chairman]] OR [[:NRC/EDO]] OR [[:NRC/FSME]] OR [[:NRC/IS]] OR [[:NRC/OCAA]] OR [[:NRC/OCFO]] OR [[:NRC/OCIO]] OR [[:NRC/OCM]] OR [[:NRC/OE]] OR [[:NRC/OEDO]] OR [[:NRC/OGC]] OR [[:NRC/OI]] OR [[:NRC/OIG]] OR [[:NRC/OIP]] , [[Division::+]]</code>. Office of Nuclear Reactor Regulation
Division of Licensing Projects Japan Lessons-Learned Division Division of Policy and Rulemaking Division of Inspection and Regional Support Division of Materials and License Renewal Division of Operating Reactor Licensing Division of Regulatory Improvement Programs Division of Systems Safety and Analysis Office of Nuclear Material Safety and Safeguards
Division of Fuel Cycle Safety, Safeguards, and Environmental Review Division of Spent Fuel Management Division of Decommissioning, Uranium Recovery and Waste Programs
Division of Construction Inspection and Operational Programs Office of Nuclear Security and Incident Response
Division of Security Operations Office of Nuclear Regulatory Research
Division of Engineering Technology
Acquisition Management Division Division of Administrative Services Office of the Chief Human Capital Officer
Office of Information Services
Office of Public Affairs Region I Office of Public Affairs Region II
Some use of "" in your query was not closed by a matching "". |
Region 1Division
Branch
Region 2Division
Branch
Region 3Division
Branch
Region 4Division
Branch
| |
| from | MONTHYEARML24351A0312024-12-160Issue date: 16 December 2024 Title: Licensing Support Network Advisory Review Panel (Lsnarp); Notice of Renewal ML24340A0962024-12-020Issue date: 2 December 2024 Title: 12-02-24 Advisory Committee on Reactor Safeguards: Charter Renewal ML24289A1952024-10-090Issue date: 9 October 2024 Title: Follow-up Email Dated October 9, 2024 from the Office of the Secretary to Wallace Taylor Regarding the Filing Error ML24289A1942024-10-080Issue date: 8 October 2024 Title: Email Dated October 8, 2024 from the Office of the Secretary to the Participants of the Palisades 50-255 & 72-007 LT-3 Proceeding Regarding Filing Error ML24289A1932024-10-080Issue date: 8 October 2024 Title: Email Dated October 9, 2024 from the Office of the Secretary to Wallace Taylor Regarding Filing Error ML24184A4752024-07-090Issue date: 9 July 2024 Title: ACMUI Notice of Meeting August 29 2024 ML24149A3542024-05-290Issue date: 29 May 2024 Title: ACMUI Notice of Meeting June 17 2024 ML24137A0182024-05-160Issue date: 16 May 2024 Title: ACMUI Notice of Meeting June 5 2024 Correction ML24122C6792024-05-020Issue date: 2 May 2024 Title: ACMUI Notice of Meeting June 5 2024 ML24067A0902024-03-050Issue date: 5 March 2024 Title: Email to Diane Curran from the Office of the Secretary, Assistant for Rulemaking and Adjudications, Russell Chazell ML24061A2272024-03-040Issue date: 4 March 2024 Title: ACMUI Notice of Meeting April 8-9 2024 ML24059A0272024-02-280Issue date: 28 February 2024 Title: 02-28-24 Advisory Committee on the Medical Uses of Isotopes (Acmui); Charter Renewal ML24059A1232024-02-280Issue date: 28 February 2024 Title: Advisory Committee on the Medical Uses of Isotopes: Charter Renewal ML24059A1242024-02-280Issue date: 28 February 2024 Title: Charter for the Advisory Committee on the Medical Uses of Isotopes ML24059A1282024-02-280Issue date: 28 February 2024 Title: Letter to the Library of Congress, Federal Advisory Committee Desk, Mr. Miroslav Lazarevich Regarding the Advisory Committee on the Medical Uses of Isotopes Renewed Charter ML24053A3602023-12-010Issue date: 1 December 2023 Title: 2023 Annual Report - Review of Federal Advisory Committee ML23128A0942023-05-090Issue date: 9 May 2023 Title: 706th Full Committee Meeting of the Advisory Committee on Reactor Safeguards, June 7-9, 2023 ML23104A0622023-05-010Issue date: 1 May 2023 Title: Advisory Committee on the Medical Uses of Isotopes (ACMUI) Notice of Meeting, May 15-16, 2023 ML23074A1112023-03-140Issue date: 14 March 2023 Title: Office of the Secretary Email Regarding Filing of Hearing Request from San Luis Obispo Mothers for Peace Regarding Diablo Canyon ISFSI License Renewal Application ML23061A1642023-03-010Issue date: 1 March 2023 Title: Email Transmitting a Copy of the Order of the Secretary Denying Petition for Declaratory Order to Representatives of the Applicant ML23040A3392023-02-090Issue date: 9 February 2023 Title: Official Exhibit - PSO004-00-BD01 - Usdoe Office of Civilian Radioactive Waste Management Acceptance Priority Ranking and Annual Capacity Report. March 1995 ML23040A3412023-02-090Issue date: 9 February 2023 Title: Certificate of Service for Presiding Officer Exhibit (PSO004) ML22363A1892022-12-160Issue date: 16 December 2022 Title: Letter to the Library of Congress Providing Copy of 2023 Charter Renewal for the Licensing Support Network Advisory Review Panel ML22363A1912022-12-160Issue date: 16 December 2022 Title: 2023 FACA Charter Renewal for the Licensing Support Network Advisory Review Panel ML22363A1922022-12-160Issue date: 16 December 2022 Title: 2023 Membership Balance Plan for the Licensing Support Network Advisory Review Panel ML22363A1932022-12-160Issue date: 16 December 2022 Title: Federal Register Notice for the 2023 FACA Charter Renewal of the Licensing Support Network Advisory Review Panel ML22357A0512022-12-020Issue date: 2 December 2022 Title: Letter to the Library of Congress from Russell Chazell, Providing the 2022 FACA Charter Renewal for the Advisory Committee on Reactor Safeguards ML22357A0502022-12-020Issue date: 2 December 2022 Title: 2022 Membership Balance Plan for the Advisory Committee on Reactor Safeguards ML22357A0462022-12-020Issue date: 2 December 2022 Title: Letter to the Honorable Frank Pallone, Jr. from Eugene Dacus, OCA, Providing the 2022 FACA Charter Renewal for the Advisory Committee on Reactor Safeguards ML22357A0472022-12-020Issue date: 2 December 2022 Title: Letter to the Honorable Thomas R. Carper from Eugene Dacus, OCA, Providing the 2022 FACA Charter Renewal for the Advisory Committee on Reactor Safeguards ML22357A0482022-12-020Issue date: 2 December 2022 Title: Federal Register Notice for the 2022 FACA Charter Renewal of the Advisory Committee on Reactor Safeguards ML22357A0492022-12-020Issue date: 2 December 2022 Title: 2022 FACA Charter Renewal for the Advisory Committee on Reactor Safeguards ML24053A3592022-12-010Issue date: 1 December 2022 Title: 2022 Annual Report - Review of Federal Advisory Committee ML22271A9762022-09-280Issue date: 28 September 2022 Title: Action Referral - Appeal of Denial of SUNSI Access - Nuclear Fuel Services, Inc. License Amendment Application ML22256A2402022-09-140Issue date: 14 September 2022 Title: 699th Full Committee Meeting of the Advisory Committee on Reactor Safeguards, October 5-7, 2022 ML22216A0322022-08-050Issue date: 5 August 2022 Title: 698th Full Committee Meeting of the Advisory Committee on Reactor Safeguards, September 7-9, 2022 ML22041A4552022-02-080Issue date: 8 February 2022 Title: M220208: Transcript - Meeting with the Organization of Agreement States and the Conference of Radiation Control Program ML24053A3582021-12-010Issue date: 1 December 2021 Title: 2021 Annual Report - Review of Federal Advisory Committee ML20366A0312020-12-300Issue date: 30 December 2020 Title: Federal Register Notice for the 2021 FACA Charter Renewal of the Licensing Support Network Advisory Review Panel ML20366A0282020-12-300Issue date: 30 December 2020 Title: 2021 FACA Charter Renewal for the Licensing Support Network Advisory Review Panel ML20366A0292020-12-300Issue date: 30 December 2020 Title: Letter to the Library of Congress Providing Copy of 2021 Charter Renewal for the Licensing Support Network Advisory Review Panel ML20366A0302020-12-300Issue date: 30 December 2020 Title: 2021 Membership Balance Plan for the Licensing Support Network Advisory Review Panel ML20337A1192020-12-020Issue date: 2 December 2020 Title: Letter to the Library of Congress from Russell Chazell, Providing the 2020 FACA Charter Renewal for the Advisory Committee on Reactor Safeguards ML20337A1182020-12-020Issue date: 2 December 2020 Title: 2020 Membership Balance Plan for the Advisory Committee on Reactor Safeguards ML20337A1172020-12-020Issue date: 2 December 2020 Title: 2020 FACA Charter Renewal for the Advisory Committee on Reactor Safeguards ML20337A1162020-12-020Issue date: 2 December 2020 Title: Federal Register Notice for the 2020 FACA Charter Renewal for the Advisory Committee on Reactor Safeguards ML24053A3632020-12-010Issue date: 1 December 2020 Title: 2020 Annual Report - Review of Federal Advisory Committee ML20325A2552020-11-200Issue date: 20 November 2020 Title: Advisory Committee on the Medical Uses of Isotopes (ACMUI) Call for Nominations for Patients Rights Advocate ML20220A6752020-08-070Issue date: 7 August 2020 Title: Memo to File Regarding Withdrawal of Comment Request Submitted by Lisa E. Gordon-Hagerty on Behalf of National Nuclear Security Administration ML20190A1272020-07-230Issue date: 23 July 2020 Title: Advisory Committee on the Medical Uses of Isotopes (ACMUI) Meeting Notice for September 21-22, 2020 ML20064F8502020-02-280Issue date: 28 February 2020 Title: Letter to the Library of Congress Providing Copy of 2020 FACA Charter Renewal for the Advisory Committee on the Medical Use of Isotopes ML20064F8522020-02-280Issue date: 28 February 2020 Title: 2020 Membership Balance Plan for the Advisory Committee on the Medical Uses of Isotopes ML20064F8512020-02-280Issue date: 28 February 2020 Title: 2020 FACA Charter Renewal for the Advisory Committee on the Medical Uses of Isotopes ML20064F8482020-02-280Issue date: 28 February 2020 Title: Letter to the Honorable John Barrasso from Eugene Dacus, OCA, Providing Copy of the 2020 FACA Charter Renewal for the Advisory Committee on Medical Uses of Isotopes ML20065H1642020-02-280Issue date: 28 February 2020 Title: 02-28-20 Advisory Committee on the Medical Uses of Isotopes (ACMUI) Charter Renewal - Notice of Renewal Until February 28, 2022 ML24053A3622019-12-020Issue date: 2 December 2019 Title: 2019 Annual Report - Review of Federal Advisory Committee ML19261A8602019-09-180Issue date: 18 September 2019 Title: Clinch River Mandatory Hearing on Early Site Permit - Information Regarding Location/Cross References of Hearing Transcript and Transcript Corrections ML19106A2572019-01-030Issue date: 3 January 2019 Title: Letters to the Honorable John Barrasso and Frank Pallone from Eugene Dacus, OCA, Providing Copy of 2019 Charter Renewal for the Licensing Support Network Advisory Review Panel ML19106A2562019-01-030Issue date: 3 January 2019 Title: Letter to the Library of Congress Providing Copy of 2019 Charter Renewal for the Licensing Support Network Advisory Review Panel ML19106A2552019-01-030Issue date: 3 January 2019 Title: 2019 Membership Balance Plan for the Licensing Support Network Advisory Review Panel ML19106A2542019-01-030Issue date: 3 January 2019 Title: 2019 FACA Charter Renewal for the Licensing Support Network Advisory Review Panel ML24053A3612018-12-030Issue date: 3 December 2018 Title: 2018 Annual Report - Review of Federal Advisory Committee ML19106A2162018-12-030Issue date: 3 December 2018 Title: 2018 FACA Charter Renewal for the Advisory Committee on Reactor Safeguards ML19106A2172018-12-030Issue date: 3 December 2018 Title: 2018 Membership Balance Plan for the Advisory Committee on Reactor Safeguards ML19106A2182018-12-030Issue date: 3 December 2018 Title: Letter to the Library of Congress Providing Copy of 2018 FACA Charter Renewal for the Advisory Committee on Reactor Safeguards ML19106A2192018-12-030Issue date: 3 December 2018 Title: Letters to the Honorable John Barrasso and Greg Walden from Eugene Dacus, OCA, Providing the 2018 FACA Charter Renewal for the Advisory Committee on Reactor Safeguards ML18149A5962018-05-260Issue date: 26 May 2018 Title: Comment (020) from an Anonymous Individual on the Requirements for the Indefinite Storage of Spent Nuclear Fuel ML18107A8092018-03-280Issue date: 28 March 2018 Title: E-mail from Brian Newell, Nrc/Secy, to NRC Licensing Support Network Advisory Review Panel (LSNARP) Staff, Regarding Status Update for Prairie Island Indian Community and White Pine County, Nv Comments Following February 27-28, 2018 LSNARP ML19107A1302018-03-010Issue date: 1 March 2018 Title: Letter to the Library of Congress Providing Copy of 2018 FACA Charter Renewal for the Advisory Committee on the Medical Use of Isotopes ML19107A0432018-03-010Issue date: 1 March 2018 Title: 2018 Membership Balance Plan for the Advisory Committee on the Medical Uses of Isotopes ML19107A0442018-03-010Issue date: 1 March 2018 Title: 2018 FACA Charter Renewal for the Advisory Committee on the Medical Uses of Isotopes DD-17-04, Letters to Licensees Omitted from Distribution of Order Extending Commission Review Time for Directors Decision DD-17-042018-01-100Issue date: 10 January 2018 Title: Letters to Licensees Omitted from Distribution of Order Extending Commission Review Time for Directors Decision DD-17-04 ML17353A1962017-12-180Issue date: 18 December 2017 Title: E-mail to LSNARP Members Regarding Licensing Support Network Advisory Review Panel Meeting - Federal Register Notice ML17353A1982017-12-180Issue date: 18 December 2017 Title: Attachment 3 - Instructions for Virtual Meeting Attendance Via Gotomeeting by LSNARP Member Representatives ML16182A4182016-06-300Issue date: 30 June 2016 Title: June 20, 2016 Service of Commission Meeting Transcript ML14321A7422014-11-170Issue date: 17 November 2014 Title: Letter from Emile Julian to Timothy Rausch Providing Comments from Eric Epstein Regarding Susquehanna Steam Electric Station, Units 1 and 2 and ISFSI; Application for License Transfer ML14308A6402014-11-030Issue date: 3 November 2014 Title: Letter from Emile Julian to Timothy Rausch Providing Comments Submitted Regarding Susquehanna Steam Electric Station, Units 1 and 2 and ISFSI; Application for License Transfer ML14182A6072014-07-010Issue date: 1 July 2014 Title: Notice of Service of Commission Meeting Transcript ML14101A3882014-04-110Issue date: 11 April 2014 Title: Service of Commission Meeting Transcript M130108, SRM-M130108 - Briefing on Fort Calhoun Station, 9:00 A.M. Tuesday, January 8, 2013, Commissioners' Conference Room, One White Flint North, Rockville, Maryland (Open to Public Attendance)2013-01-220Issue date: 22 January 2013 Title: SRM-M130108 - Briefing on Fort Calhoun Station, 9:00 A.M. Tuesday, January 8, 2013, Commissioners' Conference Room, One White Flint North, Rockville, Maryland (Open to Public Attendance) ML13022A4282013-01-220Issue date: 22 January 2013 Title: SRM-M130108 - Briefing on Fort Calhoun Station, 9:00 A.M. Tuesday, January 8, 2013, Commissioners Conference Room, One White Flint North, Rockville, Maryland (Open to Public Attendance) SECY-12-0135, M121012 - Affirmation Session: SECY-12-0135 - Entergy Nuclear Operations, Inc. (Indian Point Units 2 and 3) - Entergys Petition for Interlocutory Review of Board Order Granting Cross-Examination to New York State and Entergys Stay Reque2012-10-120Issue date: 12 October 2012 Title: M121012 - Affirmation Session: SECY-12-0135 - Entergy Nuclear Operations, Inc. (Indian Point Units 2 and 3) - Entergys Petition for Interlocutory Review of Board Order Granting Cross-Examination to New York State and Entergys Stay Request ML12276A4042012-10-020Issue date: 2 October 2012 Title: Note to the Parties Non-Public Copyright Exhibits List ML12258A3412012-09-120Issue date: 12 September 2012 Title: Limited Appearance Statement of Jessica Winston Opposing Indian Point, Units 2 and 3 License Renewal Application ML12024A4332012-01-180Issue date: 18 January 2012 Title: Transcript of the Entergy Nuclear Operations, Inc., Indian Point, Units 2 & 3, Pre-Hearing Conference, Wednesday, January 18, 2012, Pages 1054-1100 ML1103200832011-01-120Issue date: 12 January 2011 Title: Email to Robert Leyse Regarding His Submission of January 11, 2011 ML0823410512008-08-210Issue date: 21 August 2008 Title: Commission Order - Oyster Creek ML0823407172008-08-190Issue date: 19 August 2008 Title: Julian Email to Saporito Regarding Petition Submission ML0823304172008-08-120Issue date: 12 August 2008 Title: NRC Staff Exhibit List - Vermont Yankee Nuclear Power Station July 2008 Evidentiary Hearing ML0823304192008-08-120Issue date: 12 August 2008 Title: July 2008 Evidentiary Hearing, New England Coalition Exhibit List ML0726205492007-09-110Issue date: 11 September 2007 Title: Request for Extension of Time to File Hearing Request, by Alison H. Crocker, New York State Dept. of Environmental Conservation ML0619303662006-06-260Issue date: 26 June 2006 Title: Transcript of Limited Appearance Statements Held in Brattleboro, VT; pp.1 - 94 ML0527201292005-09-280Issue date: 28 September 2005 Title: Letter from Emile L. Julian Diane Curran Requesting Return of Safeguards Documents ML0418905592004-07-070Issue date: 7 July 2004 Title: Commission Memorandum and Order (CLI-04-18) ML0418905642004-07-070Issue date: 7 July 2004 Title: Commission Memorandum and Order (CLI-04-19) ML0418106512004-06-250Issue date: 25 June 2004 Title: Letter from Annette L. Vietti-Cook to Mitchell Mickey J. Maricque Responding to His Request for a Hearing ML0234003322002-12-060Issue date: 6 December 2002 Title: Memorandum from Emile L. Julian to Recipients of Letter Dated 12/04/02 from Annette L. Vietti-Cook to Norm Cohen Regarding DD-02-03 ML0212702452002-05-020Issue date: 2 May 2002 Title: Letter Acknowledging Receipt of Ltr. from Laura Stamas Sent to Chairman Meserve Regarding Vermont Yankee Nuclear Power Plant 2024-07-09 |
| to | MONTHYEARML25254A0542025-09-110Issue date: 11 September 2025 Title: Written Limited Appearance Statement from John Kleb ML25206A1452025-07-250Issue date: 25 July 2025 Title: Non-Disclosure Agreements - San Antonio Bay Estuarine Waterkeeper - Marisa Perales Et Al ML25147A0242025-05-270Issue date: 27 May 2025 Title: Eric Joseph Epsteins Request to Bar Receipt of New Fuel to Support Potential Restart of the Facility ML25083A2312025-03-210Issue date: 21 March 2025 Title: Comment (008) from Judi Greenwald on Behalf of Nuclear Innovation Alliance on PR-170 and 171 - Fee Schedules; Fee Recovery for Fiscal Year 2025 ML25083A2372025-03-210Issue date: 21 March 2025 Title: Comment (014) from David Terry on Behalf of the National Association of State Energy Officials (Naseo) on PR-170 and 171 - Fee Schedules; Fee Recovery for Fiscal Year 2025 ML25083A2362025-03-200Issue date: 20 March 2025 Title: Comment (013) from Gabrielle Schreier on Behalf of GE Hitachi Nuclear Energy on PR-170 and 171 - Fee Schedules; Fee Recovery for Fiscal Year 2025 ML25073A0122025-03-130Issue date: 13 March 2025 Title: Comment (004) from Wayne A. Norton on Behalf of Decommissioning Plant Coalition (DPC) on PR-170 and 171 - Fee Schedules Fee Recovery for Fiscal Year 2025 ML25072A0252025-03-030Issue date: 3 March 2025 Title: Comment (012) from Alyse Peterson on Behalf of New York State Energy Research and Development Authority (NYSERDA) on PR-73 - Law Enforcement Response in Power Reactor ML25063A0062025-03-030Issue date: 3 March 2025 Title: Comment (010) from David Young on Behalf of Nuclear Energy Institute on PR-73 - Law Enforcement Response in Power Reactor Physical Protection Programs ML25044A4192025-02-110Issue date: 11 February 2025 Title: Comment (075) from Lizzie Mcfee on Part 53 Rulemaking - Risk-Informed Technology-Inclusive Regulatory Framework for Advanced Reactors NRC-2024-0173, Comment (016) from Kimberly D. Hulvey on Behalf of Tennessee Valley Authority (TVA) on PRM-50-126 - Technical Specifications for Nuclear Power Reactors2025-02-100Issue date: 10 February 2025 Title: Comment (016) from Kimberly D. Hulvey on Behalf of Tennessee Valley Authority (TVA) on PRM-50-126 - Technical Specifications for Nuclear Power Reactors ML25042A6002025-02-100Issue date: 10 February 2025 Title: Comment (019) from Kenneth A. Mack on Behalf of Florida Power & Light and NextEra on PRM-50-126 - Technical Specifications for Nuclear Power Reactors ML25042A5602025-02-100Issue date: 10 February 2025 Title: Comment (015) from Shawn K. Gibby on Behalf of Duke Energy on PRM-50-126 - Technical Specifications for Nuclear Power Reactors ML25042A5852025-02-060Issue date: 6 February 2025 Title: Comment (017) from Jamie M. Coleman on Behalf of Southern Nuclear Operating Company (SNC) on PRM-50-126 - Technical Specifications for Nuclear Power Reactors ML25042A0942025-02-060Issue date: 6 February 2025 Title: Comment (014) from Mitch S. Dior on Behalf of BWR Owners Group (BWROG) on PRM-50-126 - Technical Specifications for Nuclear Power Reactors ML25037A2332025-02-060Issue date: 6 February 2025 Title: Comment (011) by Victoria Anderson on Behalf of Nuclear Energy Institute (NEI) on PRM-50-126 - Technical Specifications for Nuclear Power Reactors ML25038A1292025-02-050Issue date: 5 February 2025 Title: Comment (013) from Jim Lynde on Behalf of Pressurized Water Reactor (PWR) Owners Group on PRM-50-126 - Technical Specifications for Nuclear Power Reactors ML25038A1282025-02-040Issue date: 4 February 2025 Title: Comment (012) from David Mannai on Behalf of PSEG Nuclear, LLC on PRM-50-126 - Technical Specifications for Nuclear Power Reactors ML25036A0082025-01-300Issue date: 30 January 2025 Title: Comment (010) by James E. Holloway on Behalf of Dominion Energy Services, Inc. on PRM-50-126 - Technical Specifications for Nuclear Power Reactors ML25083A0672025-01-270Issue date: 27 January 2025 Title: Comment (022) from Kevin Lueshen on Behalf of Constellation Energy Generation, LLC on PRM-50-126 - Technical Specifications for Nuclear Power Reactors ML25027A4142025-01-270Issue date: 27 January 2025 Title: Comment (008) from Michael K. Scarpello on Behalf of Indiana Michigan Power Company (I&M) on PRM-50-126 - Technical Specifications for Nuclear Power Reactors ML25031A0052025-01-240Issue date: 24 January 2025 Title: Comment (009) from Michael D. Dilorenzo on Behalf of Arizona Public Service Company on PRM-50-126 - Technical Specifications for Nuclear Power Reactors ML25024A0102025-01-230Issue date: 23 January 2025 Title: Comment (007) from A.M. Richards, Jr. on Behalf of STP Nuclear Operating Company on PRM-50-126 - Technical Specifications for Nuclear Power Reactors ML25022A3062025-01-220Issue date: 22 January 2025 Title: Letter from T. Basso, NEI to C. Araguas Regarding Request for Input and Comment on Current 10 CFR 55a Rulemaking ML25024A0082025-01-220Issue date: 22 January 2025 Title: Comment (005) from Linda Dewhirst on Behalf of Nebraska Public Power District on PRM-50-126 - Technical Specifications for Nuclear Power Reactors ML25065A0342025-01-220Issue date: 22 January 2025 Title: Petition for Rulemaking from Thomas Basso on Behalf of the Nuclear Energy Institute to Revise Industry Codes and Standards for Production and Utilization Facilities ML25024A0092025-01-220Issue date: 22 January 2025 Title: Comment (006) from Sara L. Scott on Behalf of Northern States Power Company (Xcel Energy) on PRM-50-126 - Technical Specifications for Nuclear Power Reactors ML25013A1782025-01-100Issue date: 10 January 2025 Title: Comment (047) from Michael F. Keller on Behalf of Hybrid Power Technologies, LLC on Part 53 Rulemaking - Risk-Informed Technology-Inclusive Regulatory Framework for Advanced Reactors ML25013A0302025-01-100Issue date: 10 January 2025 Title: Comment (004) from Peter Dietrich on Behalf of DTE Electric Company on PRM-50-126 - Technical Specifications for Nuclear Power Reactors ML25013A1772025-01-090Issue date: 9 January 2025 Title: Comment (046) from Michael F. Keller on Behalf of Hybrid Power Technologies, LLC on Part 53 Rulemaking - Risk-Informed Technology-Inclusive Regulatory Framework for Advanced Reactors ML25013A0162025-01-090Issue date: 9 January 2025 Title: Comment (003) from Donald Hoffman on Behalf of Excel Services Corporation on PRM-50-126 - Technical Specifications for Nuclear Power Reactors ML25013A1762025-01-080Issue date: 8 January 2025 Title: Comment (045) from Michael F. Keller on Behalf of Hybrid Power Technologies, LLC on Part 53 Rulemaking - Risk-Informed Technology-Inclusive Regulatory Framework for Advanced Reactors ML25013A1752025-01-080Issue date: 8 January 2025 Title: Comment (044) from Michael F. Keller on Behalf of Hybrid Power Technologies, LLC on Part 53 Rulemaking - Risk-Informed Technology-Inclusive Regulatory Framework for Advanced Reactors ML25002A2342025-01-020Issue date: 2 January 2025 Title: Comment (002) from Philip Couture on Behalf of Entergy on PRM-50-126 - Technical Specifications for Nuclear Power Reactors ML25013A1792025-01-020Issue date: 2 January 2025 Title: Comment (048) from Michael F. Keller on Behalf of Hybrid Power Technologies, LLC on Part 53 Rulemaking - Risk-Informed Technology-Inclusive Regulatory Framework for Advanced Reactors ML24354A0672024-12-180Issue date: 18 December 2024 Title: Comment (031) from M. Oneill on Behalf of NEI on PR-51 -Generic Environmental Impact Statement for Licensing of New Nuclear Reactors ML24353A3052024-12-180Issue date: 18 December 2024 Title: Comment (024) from Emy Lesofski on Behalf of Utah Office of Energy Development on PR-51 - Generic Environmental Impact Statement for Licensing of New Nuclear Reactors ML24354A0512024-12-180Issue date: 18 December 2024 Title: Comment (028) from Alyse Peterson on Behalf of NYSERDA on PR-51 - Generic Environmental Impact Statement for Licensing of New Nuclear Reactors ML24353A2362024-12-180Issue date: 18 December 2024 Title: Comment (021) from Anthony Schoedel on Behalf of Westinghouse Electric Company on PR-51 - Generic Environmental Impact Statement for Licensing of New Nuclear Reactors ML24354A0612024-12-180Issue date: 18 December 2024 Title: Comment (030) from Peter Hastings on Behalf of Kairos Power, LLC on PR-51 - Generic Environmental Impact Statement for Licensing of New Nuclear Reactors ML25015A1382024-12-130Issue date: 13 December 2024 Title: Comment (036) by S. Reynolds on Behalf of the Illinois Emergency Management Agency and Office of Homeland Security (IEMA-OHS) on PR-51 - Generic Environmental Impact Statement for Licensing of New Nuclear Reactors ML24345A1932024-11-240Issue date: 24 November 2024 Title: Comment (030) from Tom Gurdziel on Part 53 Rulemaking - Risk-Informed Technology-Inclusive Regulatory Framework for Advanced Reactors ML25015A1032024-11-200Issue date: 20 November 2024 Title: Comment (049) from Tom Gurdziel on Part 53 Rulemaking - Risk-Informed Technology-Inclusive Regulatory Framework for Advanced Reactors ML24297A4262024-10-230Issue date: 23 October 2024 Title: Comment (006) from Christopher P. Chwasz on Behalf of the Advanced Reactor Regulatory Coordination and Integration Group on PR-50, 52 and 73 - Alternative Physical Security Requirements for Advanced Reactors ML24298A0672024-10-230Issue date: 23 October 2024 Title: Comment (012) from the Council of Intelligent Energy & Conservation Policy and Promoting Health and Sustainable Energy on PR-50, 52 and 73 - Alternative Physical Security Requirements for Advanced Reactors ML24312A3362024-10-230Issue date: 23 October 2024 Title: Comment (015) from Alyse Peterson on Behalf of the New York State Research and Development Authority on PR-50, 52 and 73 - Alternative Physical Security Requirements for Advanced Reactors ML24298A0662024-10-230Issue date: 23 October 2024 Title: Comment (011) from Edwin Lyman on Behalf of the Union of Concerned Scientists on PR-50, 52 and 73 - Alternative Physical Security Requirements for Advanced Reactors ML24295A0342024-10-170Issue date: 17 October 2024 Title: Comment (003) from Anthony J. Schoedel on Behalf of Westinghouse Electric Company on PR-50, 52 and 73 - Alternative Physical Security Requirements for Advanced Reactors ML24289A1962024-10-100Issue date: 10 October 2024 Title: Email Dated October 10, 2024 from Wallace Taylor Indicating His Intention to Refile ML24264A1122024-09-200Issue date: 20 September 2024 Title: Comment (008) from Martin J. Oneill on Behalf of the Nuclear Energy Institute on PR-51 - Categorical Exclusions from Environmental Review ML24250A0072024-09-160Issue date: 16 September 2024 Title: Designation of Federal Employees as the Dfo for the ACMUI ML24262A2522024-09-160Issue date: 16 September 2024 Title: Comment (007) from the Nuclear Energy Tribal Working Group on PR-51 - Categorical Exclusions from Environmental Review TSTF-24-07, PRM-50-126 - Petition for Rulemaking to Amend 10 CFR 50.36, Technical Specifications from Brian D. Mann on Behalf of the Technical Specifications Task Force2024-09-130Issue date: 13 September 2024 Title: PRM-50-126 - Petition for Rulemaking to Amend 10 CFR 50.36, Technical Specifications from Brian D. Mann on Behalf of the Technical Specifications Task Force ML24152A1372024-04-250Issue date: 25 April 2024 Title: Comment (009) from Anthony S. on Behalf of the Nez Perce Tribe on PR-37 - Advance Tribal Notification of Category 1 Quantities of Radioactive Material Shipments ML24082A2292024-03-210Issue date: 21 March 2024 Title: Comment (008) of Nader Mamish on Behalf of Westinghouse Electric Company, LLC, on PR-2, 15, 37, 73, 110, 140, 170 and 171 - Fee Schedules; Fee Recovery for Fiscal Year 2024 ML24082A0972024-03-210Issue date: 21 March 2024 Title: Comment (005) of Jennifer Uhle on Behalf of the Nuclear Energy Institute on PR-2, 15, 37, 73, 110, 140, 170 and 171 - Fee Schedules; Fee Recovery for Fiscal Year 2024 ML24082A2302024-03-210Issue date: 21 March 2024 Title: Comment (009) of Sara L. Scott on Behalf of Xcel Energy/Northern States Power Company - Minnesota, on PR-2, 15, 37, 73, 110, 140, 170 and 171 - Fee Schedules; Fee Recovery for Fiscal Year 2024 ML24082A2282024-03-210Issue date: 21 March 2024 Title: Comment (007) of Kevin Lueshen on Behalf of Constellation Energy Generation, LLC, on PR-2, 15, 37, 73, 110, 140, 170 and 171 - Fee Schedules; Fee Recovery for Fiscal Year 2024 ML24082A1912024-03-210Issue date: 21 March 2024 Title: Comment (006) from NextEra Energy Duane Arnold, LLC on PR-2, 15, 37, 73, 110, 140, 170 and 171 - Fee Schedules; Fee Recovery for Fiscal Year 2024 ML24080A0632024-03-190Issue date: 19 March 2024 Title: Comment (004) of Gary D. Camper on Behalf of Bwx Technologies, Inc. on PR-2, 15, 37, 73, 110, 140, 170 and 171 - Fee Schedules; Fee Recovery for Fiscal Year 2024 ML24080A0622024-03-150Issue date: 15 March 2024 Title: Comment (003) of Wayne Norton on Behalf of the Decommissioning Plant Coalition on PR-2, 15, 37, 73, 110, 140, 170 and 171 - Fee Schedules; Fee Recovery for Fiscal Year 2024 ML24067A0892024-03-050Issue date: 5 March 2024 Title: Email Response from Diane Curran to Office of the Secretary, Assistant for Rulemaking and Adjudications, Russell Chazell ML24023A6042024-01-220Issue date: 22 January 2024 Title: Comment (011) from Jennifer Uhle on Behalf of the Nuclear Energy Institute on PR-50, 51, and 71 - Increased Enrichment of Conventional and Accident Tolerant Fuel Designs for Light-Water Reactors ML24024A0712024-01-220Issue date: 22 January 2024 Title: Comment (014) from Gayle Elliott on Behalf of Framatome Inc. on PR-50, 51, and 71 - Increased Enrichment of Conventional and Accident Tolerant Fuel Designs for Light-Water Reactors ML24016A0272024-01-120Issue date: 12 January 2024 Title: Comment (025) from Todd Pawlicki on Behalf of American Association of Physicists in Medicine on PR-35 - Rubidium-82 Generators, Emerging Technologies, and Other Medical Use of Byproduct Material ML23352A2152023-12-180Issue date: 18 December 2023 Title: Petitioners Reply in Support of Petition for Leave to Intervene ML23349A1282023-12-150Issue date: 15 December 2023 Title: Comment (017) from Mouaz Al Mallah on Behalf of the American Society of Nuclear Cardiology on PR-35 - Rubidium-82 Generators, Emerging Technologies, and Other Medical Use of Byproduct Material ML23352A2632023-12-150Issue date: 15 December 2023 Title: Comment (020) from Helen Nadel on Behalf of the Society of Nuclear Medicine and Molecular Imaging on PR-35 - Rubidium-82 Generators, Emerging Technologies, and Other Medical Use of Byproduct Material ML23349A0402023-12-150Issue date: 15 December 2023 Title: Comment (015) from Bob Thomas of Elekta, Inc. on PR-35 - Rubidium-82 Generators, Emerging Technologies, and Other Medical Use of Byproduct Material ML23349A1272023-12-150Issue date: 15 December 2023 Title: Comment (016) from Laura I. Thevenot on Behalf of the American Society for Radiation Oncology on PR-35 - Rubidium-82 Generators, Emerging Technologies, and Other Medical Use of Byproduct Material ML23352A2622023-12-150Issue date: 15 December 2023 Title: Comment (019) from Glenn M. Sturchio on Behalf of the Mayo Clinic PR-35 - Rubidium-82 Generators, Emerging Technologies, and Other Medical Use of Byproduct Material ML23348A1232023-12-140Issue date: 14 December 2023 Title: Comment (011) from Michael P. Roberson on Behalf of the National Institutes of Health on PR-35 - Rubidium-82 Generators, Emerging Technologies, and Other Medical Use of Byproduct Material ML23331A9652023-11-270Issue date: 27 November 2023 Title: Miami Waterkeeper - Notice of Appearance for Cameron Bills ML23331A9832023-11-270Issue date: 27 November 2023 Title: Exhibit 3 - William K. Nuttle Declaration ML23331A9812023-11-270Issue date: 27 November 2023 Title: Exhibit 18 - Jeff Mitman Declaration ML23331A9782023-11-270Issue date: 27 November 2023 Title: Exhibit 15 - Knutson Et. Al ML23331A9772023-11-270Issue date: 27 November 2023 Title: Exhibit 14 - 161617 MDC Resolution Re FPL CCS Final ML23331A9802023-11-270Issue date: 27 November 2023 Title: Exhibit 17 - Chin_Cooling Canal System at the FPL Turkey Point Power Station ML23331A9752023-11-270Issue date: 27 November 2023 Title: Exhibit 12 - Groundwater Tek Inc - Peer Review Study Final ML23331A9712023-11-270Issue date: 27 November 2023 Title: Request for Hearing and Petition to Intervene Submitted by Miami Waterkeeper ML23331A9722023-11-270Issue date: 27 November 2023 Title: Exhibit 1 - Rachel Silverstein 2023 Standing Declaration ML23331A9742023-11-270Issue date: 27 November 2023 Title: Exhibit 11 - Waterkeeper Foe Center NRDC Scoping Comments Final ML23331A9762023-11-270Issue date: 27 November 2023 Title: Exhibit 13 - ARCADIS-DERM Letter Re FPL Year 4 Raasr Final ML23331A9862023-11-270Issue date: 27 November 2023 Title: Exhibit 6 - Rebert E. Kopp Declaration ML23331A9852023-11-270Issue date: 27 November 2023 Title: Exhibit 5 - Bill Powers Declaration ML23331A9792023-11-270Issue date: 27 November 2023 Title: Exhibit 16 - Fws Species Status Assessment Miami Cave Crayfish ML23331A9842023-11-220Issue date: 22 November 2023 Title: Exhibit 4 - James Fourqurean 2023 Declaration ML23331A9892023-11-150Issue date: 15 November 2023 Title: Exhibit 9 - FPL Turkey Point Remedial Action Annual Status Report Year 5 ML23331A9822023-11-030Issue date: 3 November 2023 Title: Exhibit 2, Request for Hearing and Petition to Intervene Submitted by Miami Waterkeeper ML23296A0792023-10-180Issue date: 18 October 2023 Title: Comment Period Extension Request from the Nuclear Energy Institute on PR-50, 51, and 71 - Increased Enrichment of Conventional and Accident Tolerant Fuel Designs for Light-Water Reactors ML23289A1102023-10-160Issue date: 16 October 2023 Title: Comment (002) Dominic Siewko on Behalf of Jubilant Radiopharma on PR-35 - Rubidium-82 Generators, Emerging Technologies, and Other Medical Use of Byproduct Material ML23198A0942023-07-140Issue date: 14 July 2023 Title: Comment (053) from Alec Gorge on PR-35 - Reporting Nuclear Medicine Injection Extravasations as Medical Events ML23198A0932023-07-140Issue date: 14 July 2023 Title: Comment (052) from Meryl Gorge on PR-35 - Reporting Nuclear Medicine Injection Extravasations as Medical Events ML23198A0832023-07-130Issue date: 13 July 2023 Title: Comment (043) from Lauren Creel on PR-35 - Reporting Nuclear Medicine Injection Extravasations as Medical Events ML23198A0882023-07-130Issue date: 13 July 2023 Title: Comment (048) from Sarah Taggart on PR-35 - Reporting Nuclear Medicine Injection Extravasations as Medical Events ML23194A0702023-07-120Issue date: 12 July 2023 Title: Comment (034) from Esther E. Sciammarella on PR-35 - Reporting Nuclear Medicine Injection Extravasations as Medical Events ML23177A2492023-06-230Issue date: 23 June 2023 Title: Comment (012) from Thomas Basso on Behalf of the Nuclear Energy Institute on PR-50 - American Society of Mechanical Engineers Code Cases and Update Frequency ML23171B0022023-06-160Issue date: 16 June 2023 Title: Comment (010) from Amy C. Chamberlain on Behalf of the Southern Nuclear Operating Company on PR-50 - American Society of Mechanical Engineers Code Cases and Update Frequency ML23171B0032023-06-150Issue date: 15 June 2023 Title: Comment (011) from Thomas Basso on Behalf of the Nuclear Energy Institute on PR-50 - American Society of Mechanical Engineers Code Cases and Update Frequency ML23157A0252023-06-020Issue date: 2 June 2023 Title: Comment (018) from Dr. Carol S. Marcus on PR-35 - Reporting Nuclear Medicine Injection Extravasations as Medical Events ML23128A2782023-05-050Issue date: 5 May 2023 Title: Comment (007) from David P. Helker on Behalf of Constellation Energy Generation, LLC on PR-50 - American Society of Mechanical Engineers Code Cases and Update Frequency ML23095A0372023-04-040Issue date: 4 April 2023 Title: Comment (001) from Mark A. Richter on Behalf of the Nuclear Energy Institute on PR-50 - American Society of Mechanical Engineers Code Cases and Update Frequency ML23093A1872023-04-030Issue date: 3 April 2023 Title: Comment (005) from David M. Gullott on Behalf of Constellation Energy Generation, LLC on PR-170 and 171 - Revision of Fee Schedules; Fee Recovery for Fiscal Year 2023 ML23093A1882023-03-310Issue date: 31 March 2023 Title: Comment (003) from Dr. Jennifer L. Uhle on Behalf of the Nuclear Energy Institute on PR-170 and 171 - Revision of Fee Schedules; Fee Recovery for Fiscal Year 2023 NRC-2021-0024, Comment (004) from Richard J. Freudenberger on Behalf of BWXT Nuclear Operations Group, Inc. - Lynchburg on PR-170 and 171 - Revision of Fee Schedules; Fee Recovery for Fiscal Year 20232023-03-310Issue date: 31 March 2023 Title: Comment (004) from Richard J. Freudenberger on Behalf of BWXT Nuclear Operations Group, Inc. - Lynchburg on PR-170 and 171 - Revision of Fee Schedules; Fee Recovery for Fiscal Year 2023 ML23080A1872023-03-200Issue date: 20 March 2023 Title: Comment (002) from Dr. Adam Stein and Leigh Ann Lloveras on Behalf of the Breakthrough Institute on PR-30, 40, 50, 70 & 72 - Alternatives to the Use of Credit Ratings ML23080A1862023-03-170Issue date: 17 March 2023 Title: Comment (001) from Douglas E. True on Behalf of the Nuclear Energy Institute on PR-30, 40, 50, 70 & 72 - Alternatives to the Use of Credit Ratings ML23074A0712023-03-140Issue date: 14 March 2023 Title: Comment (007) from Ralph Meyer on PRM-50-124 - Licensing Safety Analysis for Loss-of-Coolant Accidents ML23060A4902023-02-270Issue date: 27 February 2023 Title: Declaration of Linda Hanratty in Support of Leave to Intervene in Comanche Peak Nuclear Power Plant, Units 1 and 2 License Renewal Application Proceeding ML23061A1282023-02-230Issue date: 23 February 2023 Title: Comment (004) from Gayle Elliott on Behalf of Framatome, Inc. on PRM-50-124 - Licensing Safety Analysis for Loss-of-Coolant Accidents ML23044A6222023-02-130Issue date: 13 February 2023 Title: Notice of Appearance of William David Griggs ML23038A2302023-02-060Issue date: 6 February 2023 Title: Limited Appearance Statement from Angela Couch in the Matter of Nuclear Fuel Services, Inc. License Amendment Application ML24355A1422023-02-010Issue date: 1 February 2023 Title: NIST Center for Neutron Research (NCNR) Submittal of Request for Exigent License Amendment Under 10CFR50.91(a)(6) to Make Specified Changes to Nbsr Safety Analysis Report ML23038A2292023-01-310Issue date: 31 January 2023 Title: Limited Appearance Statement from Veronica Cox in the Matter of Nuclear Fuel Services, Inc. License Amendment Application ML23060A5002023-01-300Issue date: 30 January 2023 Title: Declaration of Anita Smith in Support of Leave to Intervene in Comanche Peak Nuclear Power Plant, Units 1 and 2 License Renewal Application Proceeding ML23060A4982023-01-300Issue date: 30 January 2023 Title: Declaration of Janet Mattern in Support of Leave to Intervene in Comanche Peak Nuclear Power Plant, Units 1 and 2 License Renewal Application Proceeding ML23060A4882023-01-300Issue date: 30 January 2023 Title: Declaration of Margaret Demoss in Support of Leave to Intervene in Comanche Peak Nuclear Power Plant, Units 1 and 2 License Renewal Application Proceeding ML23038A2272023-01-300Issue date: 30 January 2023 Title: Limited Appearance Statement from Steve Cox in the Matter of Nuclear Fuel Services, Inc. License Amendment Application ML23038A2282023-01-300Issue date: 30 January 2023 Title: Limited Appearance Statement from Curtis Anthony in the Matter of Nuclear Fuel Services, Inc. License Amendment Application ML23038A2262023-01-300Issue date: 30 January 2023 Title: Limited Appearance Statement from Diane Mccarter in the Matter of Nuclear Fuel Services, Inc. License Amendment Application ML23031A2022023-01-300Issue date: 30 January 2023 Title: Comment (005) from David M. Gullott on Behalf of Constellation Energy Generation, LLC on PR-50 - Reporting Requirements for Nonemergency Events at Nuclear Power Plants ML23060A4972023-01-300Issue date: 30 January 2023 Title: Declaration of Terry Mcintire in Support of Leave to Intervene in Comanche Peak Nuclear Power Plant, Units 1 and 2 License Renewal Application Proceeding ML23026A2132023-01-260Issue date: 26 January 2023 Title: Notice of Appearance by Richard Mckay on Behalf of Eureka County, Nv ML23026A2142023-01-260Issue date: 26 January 2023 Title: Certificate of Service for Notice of Appearance of Richard Mckay ML23027A0422023-01-260Issue date: 26 January 2023 Title: Limited Appearance Statement from Duane F. Creger in the Matter of Nuclear Fuel Services, Inc. License Amendment Application ML23027A0382023-01-260Issue date: 26 January 2023 Title: Limited Appearance Statement from Joan Skewes Boone in the Matter of Nuclear Fuel Services, Inc. License Amendment Application ML23025A4032023-01-250Issue date: 25 January 2023 Title: Limited Appearance Statement from Brian Rosecrance in the Matter of Nuclear Fuel Services, Inc. License Amendment Application ML23025A3802023-01-250Issue date: 25 January 2023 Title: Limited Appearance Statement from Joan Seeman in the Matter of Nuclear Fuel Services, Inc. License Amendment Application ML23025A0802023-01-250Issue date: 25 January 2023 Title: Limited Appearance Statement from Anna Ikeda in the Matter of Nuclear Fuel Services, Inc. License Amendment Application ML23023A2752023-01-230Issue date: 23 January 2023 Title: Request for Extension of Comment Period from the Nuclear Energy Institute on PRM-50-124 - Licensing Safety Analysis for Loss-of-Coolant Accidents ML23004A0362022-12-300Issue date: 30 December 2022 Title: Comment (002) from Jeffrey Semancik on Behalf of the Nuclear Energy Advisory Council on PR-50 - Reporting Requirements for Nonemergency Events at Nuclear Power Plants ML22333A7332022-11-280Issue date: 28 November 2022 Title: Comment (011) from Wayne Norton on Behalf of the Decommissioning Plant Coalition on PR-71 - Harmonization of Transportation Safety Requirements with IAEA Standards ML22333A7352022-11-280Issue date: 28 November 2022 Title: Comment (013) from the State of Wisconsin Department of Health and Human Services on PR-71 - Harmonization of Transportation Safety Requirements with IAEA Standards ML22333A7322022-11-280Issue date: 28 November 2022 Title: Comment (010) from Michael J. Guastella on Behalf of the Council on Radionuclides and Radiopharmaceuticals, Inc. on PR-71 - Harmonization of Transportation Safety Requirements with IAEA Standards ML22333A7312022-11-220Issue date: 22 November 2022 Title: Comment (009) from the Department of Energy, National Nuclear Security Administration on PR-71 - Harmonization of Transportation Safety Requirements with IAEA Standards NRC-2016-0179, Comment (016) from Global Nuclear Fuel-Americas, LLC on PR-71 - Harmonization of Transportation Safety Requirements with IAEA Standards2022-11-170Issue date: 17 November 2022 Title: Comment (016) from Global Nuclear Fuel-Americas, LLC on PR-71 - Harmonization of Transportation Safety Requirements with IAEA Standards ML22301A1932022-10-280Issue date: 28 October 2022 Title: Park Overall Intervention Pleading (Resubmission) - Attachment 1 ML22301A1942022-10-270Issue date: 27 October 2022 Title: Park Overall Intervention Pleading (Resubmission) - Attachment 2 ML22301A1912022-10-270Issue date: 27 October 2022 Title: Park Overall Intervention Pleading (Resubmission) - Letter NRC-2022-0097, Redacted Version of Request for Access to SUNSI Information by Park Overall Regarding Nuclear Fuel Services License Amendment Application2022-09-140Issue date: 14 September 2022 Title: Redacted Version of Request for Access to SUNSI Information by Park Overall Regarding Nuclear Fuel Services License Amendment Application ML22223A0642022-08-090Issue date: 9 August 2022 Title: Comment (040) from New York State Senator James Skoufis on PR-20, 26, 50, 51, 52, 72, 73 and 140 - Regulatory Improvements for Production and Utilization Facilities Transitioning to Decommissioning ML22180A0322022-06-270Issue date: 27 June 2022 Title: Comment (006) from the Council on Radionuclides and Radiopharmaceuticals, Inc., on PR-30 and 70 - Decommissioning Financial Assurance for Sealed and Unsealed Radioactive Materials ML22180A0332022-06-270Issue date: 27 June 2022 Title: Comment (007) from the Health Physics Society on PR-30 and 70 - Decommissioning Financial Assurance for Sealed and Unsealed Radioactive Materials ML22178A2052022-06-240Issue date: 24 June 2022 Title: Comment (002) from the Low-Level Radioactive Waste Forums Disused Sources Working Group on Pr 30 and 70 - Decommissioning Financial Assurance for Sealed and Unsealed Radioactive Materials ML22178A2042022-06-240Issue date: 24 June 2022 Title: Comment (003) from Eli Lilly and Company on PR-30 and 70 - Decommissioning Financial Assurance for Sealed and Unsealed Radioactive Materials ML23332A1912021-11-150Issue date: 15 November 2021 Title: Exhibit 10 - FPL Year 3 Raasr Final ML21175A1602021-06-220Issue date: 22 June 2021 Title: Comment (005) from the Western Interstate Energy Board High-Level Radioactive Waste Committee on PRM-37-2 - Advance Tribal Notification of Certain Radioactive Material Shipments ML21175A3572021-06-070Issue date: 7 June 2021 Title: Comment (009) from Governor Stuart Paisano on Behalf of Pueblo of Sandia, Nm on PRM-37-2 - Advance Tribal Notification of Certain Radioactive Material Shipments ML21141A3282021-05-210Issue date: 21 May 2021 Title: Nuclear Information and Resource Services Request for Extension of Hearing Request and Comment Deadline (NRC-2021-0099) ML21140A4102021-05-200Issue date: 20 May 2021 Title: Certificate of Service ML21140A4092021-05-200Issue date: 20 May 2021 Title: Environmental Law and Policy Centers Motion to Extend Deadline for All Hearing Requests Regarding Exelon Generation Company, LLCs Facility Operating License Transfer Application ML21098A2452021-04-050Issue date: 5 April 2021 Title: Comment (010) from Patrick Vibien on PR-50 - Approval of American Society of Mechanical Engineers Code Cases ML21103A3372021-04-050Issue date: 5 April 2021 Title: Comment (011) from Edwin S. Lyman on PR-50 - Approval of American Society of Mechanical Engineers Code Cases ML21095A1012021-04-030Issue date: 3 April 2021 Title: Comment (007) from the American Society of Mechanical Engineers on PR-50 - Approval of American Society of Mechanical Engineers Code Cases ML21095A1002021-04-010Issue date: 1 April 2021 Title: Comment (006) from the Nuclear Energy Institute on PR-50 - Approval of American Society of Mechanical Engineers Code Cases ML21095A0982021-04-010Issue date: 1 April 2021 Title: Comment (005) from Alexander Tsirigotis on PR-50 - Approval of American Society of Mechanical Engineers Code Cases ML21090A3412021-03-310Issue date: 31 March 2021 Title: Cape Cod Time Article - Pilgrim Np Moves Spent Nuclear Fuel to Higher Elevation ML21095A0972021-03-300Issue date: 30 March 2021 Title: Comment (004) from Chakrapani Basavaraju on PR-50 - Approval of American Society of Mechanical Engineers Code Cases ML21095A0962021-03-290Issue date: 29 March 2021 Title: Comment (003) from Chakrapani Basavaraju on PR-50 - Approval of American Society of Mechanical Engineers Code Cases ML21141A3302021-03-290Issue date: 29 March 2021 Title: Comment (023) from Mimi Estrada Regarding PR-026 - Fitness for Duty Drug Testing Requirements ML21075A3222021-03-160Issue date: 16 March 2021 Title: Comment (485) from Daniel Fass on PRM-35-22 - Reporting Nuclear Medicine Intravasations as Medical Events ML21046A0692021-02-160Issue date: 16 February 2021 Title: Release. Nuclear Watchdog Alleges Three Mile Island Is in Violation of the Clean Water Act ML21046A0682021-02-160Issue date: 16 February 2021 Title: Agency Notification. Three Mile Island Is in Violation of the Clean Water Act Section 401 Certification Rule ML21034A5992021-02-030Issue date: 3 February 2021 Title: Comment (001) from Mark Moenssens on PR-50 - Approval of American Society of Mechanical Engineers Code Cases ML21048A3602021-02-010Issue date: 1 February 2021 Title: Comment (004) of Ellen C. Ginsberg on Behalf of the Nuclear Energy Institute on PR-1 - NRC Enforcement Policy ML21048A3592021-01-280Issue date: 28 January 2021 Title: Comment (003) from Anonymous of on PR-1 - NRC Enforcement Policy ML21046A0702021-01-270Issue date: 27 January 2021 Title: Enclosure. Before the Srbc, (Testimony of Eric J. Epstein, December 11, 2020) ML21048A3582021-01-250Issue date: 25 January 2021 Title: Comment (002) of Stephen Cowne on Behalf of Louisiana Energy Services, LLC on PR-1 - NRC Enforcement Policy ML20364A1292020-12-290Issue date: 29 December 2020 Title: Letter from Dr. Fred Dilger, State of Nevada - Office of the Governor, Agency for Nuclear Projects, Providing Updated Nevada LSNARP Information ML21015A4162020-11-300Issue date: 30 November 2020 Title: Comment (453) from David Lewis on PRM-35-22 - Reporting Nuclear Medicine Intravasations as Medical Events ML21019A5042020-11-300Issue date: 30 November 2020 Title: Comment (483) from Martha Silva on PRM-35-22 - Reporting Nuclear Medicine Intravasations as Medical Events ML21019A3332020-11-300Issue date: 30 November 2020 Title: Comment (464) from William White on PRM-35-22 - Reporting Nuclear Medicine Intravasations as Medical Events ML21019A3342020-11-300Issue date: 30 November 2020 Title: Comment (465) from Martin Tornai on PRM-35-22 - Reporting Nuclear Medicine Intravasations as Medical Events ML20336A2672020-11-300Issue date: 30 November 2020 Title: Comment (372) from Valerie Jewells on PRM-35-22 - Reporting Nuclear Medicine Injection Intravasations as Medical Events ML21015A4122020-11-300Issue date: 30 November 2020 Title: Comment (449) of Tonia E. Bryant on PRM-35-22 - Reporting Nuclear Medicine Intravasations as Medical Events ML21019A3292020-11-300Issue date: 30 November 2020 Title: Comment (460) from Zachary Scherzer on PRM-35-22 - Reporting Nuclear Medicine Intravasations as Medical Events ML20336A2692020-11-300Issue date: 30 November 2020 Title: Comment (374) from Angie D. Morgan Hill on PRM-35-22 - Reporting Nuclear Medicine Injection Intravasations as Medical Events ML21019A3352020-11-300Issue date: 30 November 2020 Title: Comment (466) from Josh Mailman on PRM-35-22 - Reporting Nuclear Medicine Intravasations as Medical Events ML21019A3412020-11-300Issue date: 30 November 2020 Title: Comment (471) from Max Cid on PRM-35-22 - Reporting Nuclear Medicine Intravasations as Medical Events ML21019A3322020-11-300Issue date: 30 November 2020 Title: Comment (463) from the Association for Vascular Access on PRM-35-22 - Reporting Nuclear Medicine Intravasations as Medical Events ML21019A5052020-11-300Issue date: 30 November 2020 Title: Comment (484) from Tracy King on PRM-35-22 - Reporting Nuclear Medicine Intravasations as Medical Events ML21019A4942020-11-300Issue date: 30 November 2020 Title: Comment (473) from the Organization of Agreement States on PRM-35-22 - Reporting Nuclear Medicine Intravasations as Medical Events ML21019A3382020-11-300Issue date: 30 November 2020 Title: Comment (469) from Wendy Young on PRM-35-22 - Reporting Nuclear Medicine Intravasations as Medical Events ML21019A5022020-11-300Issue date: 30 November 2020 Title: Comment (481) from Joshy Kallarackal on PRM-35-22 - Reporting Nuclear Medicine Intravasations as Medical Events ML21019A3302020-11-300Issue date: 30 November 2020 Title: Comment (461) by Anonymous Individual on PRM-35-22 - Reporting Nuclear Medicine Intravasations as Medical Events ML21019A3282020-11-300Issue date: 30 November 2020 Title: Comment (459) from Karl Fischer on PRM-35-22 - Reporting Nuclear Medicine Intravasations as Medical Events ML21019A5032020-11-300Issue date: 30 November 2020 Title: Comment (482) from Josh Knowland on PRM-35-22 - Reporting Nuclear Medicine Intravasations as Medical Events ML21019A3392020-11-300Issue date: 30 November 2020 Title: Comment (470) from Jagadesh Singh on PRM-35-22 - Reporting Nuclear Medicine Intravasations as Medical Events ML20336A2712020-11-300Issue date: 30 November 2020 Title: Comment (376) from Marija Ivanovic on PRM-35-22 - Reporting Nuclear Medicine Injection Intravasations as Medical Events ML21019A3372020-11-300Issue date: 30 November 2020 Title: Comment (468) from William Gorge on PRM-35-22 - Reporting Nuclear Medicine Intravasations as Medical Events ML21019A3362020-11-300Issue date: 30 November 2020 Title: Comment (467) from Katie Martinez on PRM-35-22 - Reporting Nuclear Medicine Intravasations as Medical Events ML20335A4842020-11-270Issue date: 27 November 2020 Title: Comment (367) from Laura Weil on PRM-35-22 - Reporting Nuclear Medicine Injection Intravasations as Medical Events ML20335A4852020-11-270Issue date: 27 November 2020 Title: Comment (368) from Darrell R. Fisher on PRM-35-22 - Reporting Nuclear Medicine Injection Intravasations as Medical Events ML20353A3832020-11-270Issue date: 27 November 2020 Title: Comment (429) from Deepak Kanda on PRM-35-22 - Reporting Nuclear Medicine Intravasations as Medical Events ML20353A3222020-11-250Issue date: 25 November 2020 Title: Comment (427) from Keith T. Kirk on PRM-35-22 - Reporting Nuclear Medicine Intravasations as Medical Events ML20353A3192020-11-240Issue date: 24 November 2020 Title: Comment (424) from Michelle Bates on PRM-35-22 - Reporting Nuclear Medicine Intravasations as Medical Events ML20353A3112020-11-220Issue date: 22 November 2020 Title: Comment (417) from Michael Matyas on PRM-35-22 - Reporting Nuclear Medicine Intravasations as Medical Events ML20353A3092020-11-210Issue date: 21 November 2020 Title: Comment (415) from Max Nikitchenko on PRM-35-22 - Reporting Nuclear Medicine Intravasations as Medical Events ML20353A1532020-11-200Issue date: 20 November 2020 Title: Comment (411) from Herbert Medford on PRM-35-22 - Reporting Nuclear Medicine Intravasations as Medical Events ML20353A1472020-11-200Issue date: 20 November 2020 Title: Comment (405) from Terry Vomocil on PRM-35-22 - Reporting Nuclear Medicine Intravasations as Medical Events ML20353A1502020-11-200Issue date: 20 November 2020 Title: Comment (408) from Katrina Underwood on PRM-35-22 - Reporting Nuclear Medicine Intravasations as Medical Events ML20335A4762020-11-180Issue date: 18 November 2020 Title: Comment (360) from Kelly Mcchuen on PRM-35-22 - Reporting Nuclear Medicine Injection Intravasations as Medical Events ML20335A4772020-11-180Issue date: 18 November 2020 Title: Comment (361) from Beth Reynolds on PRM-35-22 - Reporting Nuclear Medicine Injection Intravasations as Medical Events ML20335A4802020-11-180Issue date: 18 November 2020 Title: Comment (363) from Stephanie Obrien on PRM-35-22 - Reporting Nuclear Medicine Injection Intravasations as Medical Events ML20335A4792020-11-180Issue date: 18 November 2020 Title: Comment (362) from Beth Reynolds on PRM-35-22 - Reporting Nuclear Medicine Injection Intravasations as Medical Events ML20335A4822020-11-180Issue date: 18 November 2020 Title: Comment (365) from Kathy Ellefson on PRM-35-22 - Reporting Nuclear Medicine Injection Intravasations as Medical Events ML20335A4812020-11-180Issue date: 18 November 2020 Title: Comment (364) from Melany White on PRM-35-22 - Reporting Nuclear Medicine Injection Intravasations as Medical Events ML20335A4832020-11-180Issue date: 18 November 2020 Title: Comment (366) from Ashley Vander Poel on PRM-35-22 - Reporting Nuclear Medicine Injection Intravasations as Medical Events ML20335A4722020-11-160Issue date: 16 November 2020 Title: Comment (357) from Vijay Yerubandi on PRM-35-22 - Reporting Nuclear Medicine Injection Intravasations as Medical Events ML20335A4742020-11-160Issue date: 16 November 2020 Title: Comment (359) from Anthoula Lykouretzos on PRM-35-22 - Reporting Nuclear Medicine Injection Intravasations as Medical Events ML20325A3622020-11-150Issue date: 15 November 2020 Title: Comment (346) from Daniel Gorge on PRM-35-22 - Reporting Nuclear Medicine Injection Intravasations as Medical Events ML20325A3612020-11-150Issue date: 15 November 2020 Title: Comment (345) from Chirayu Shah on PRM-35-22 - Reporting Nuclear Medicine Injection Intravasations as Medical Events ML20325A3292020-11-140Issue date: 14 November 2020 Title: Comment (341) from David Williams on PRM-35-22 - Reporting Nuclear Medicine Injection Intravasations as Medical Events ML20325A3592020-11-140Issue date: 14 November 2020 Title: Comment (343) from Bennett S. Greenspan on PRM-35-22 - Reporting Nuclear Medicine Injection Intravasations as Medical Events ML20325A3582020-11-140Issue date: 14 November 2020 Title: Comment (342) from Tomy Kalapparambath on PRM-35-22 - Reporting Nuclear Medicine Injection Intravasations as Medical Events ML20325A3602020-11-140Issue date: 14 November 2020 Title: Comment (344) from Ron Schmitt on PRM-35-22 - Reporting Nuclear Medicine Injection Intravasations as Medical Events ML20325A3272020-11-130Issue date: 13 November 2020 Title: Comment (339) from Lisabeth Hammerlund on PRM-35-22 - Reporting Nuclear Medicine Injection Intravasations as Medical Events ML20325A3252020-11-130Issue date: 13 November 2020 Title: Comment (337) from Nancy Mcdonald on PRM-35-22 - Reporting Nuclear Medicine Injection Intravasations as Medical Events ML20325A3282020-11-130Issue date: 13 November 2020 Title: Comment (340) from Robert Wystepek on PRM-35-22 - Reporting Nuclear Medicine Injection Intravasations as Medical Events ML20317A2882020-11-080Issue date: 8 November 2020 Title: Comment (321) from Michael Blandina on PRM-35-22 - Reporting Nuclear Medicine Injection Extravasations as Medical Events ML20317A2872020-11-070Issue date: 7 November 2020 Title: Comment (320) from Delphine Chen on PRM-35-22 - Reporting Nuclear Medicine Injection Extravasations as Medical Events ML20317A2862020-11-060Issue date: 6 November 2020 Title: Comment (319) from Christina Faz on PRM-35-22 - Reporting Nuclear Medicine Injection Extravasations as Medical Events ML20302A3312020-10-280Issue date: 28 October 2020 Title: Comment (294) from Tiffinee Swanson on PRM-35-22 - Reporting Nuclear Medicine Injection Extravasations as Medical Events ML20302A3332020-10-280Issue date: 28 October 2020 Title: Comment (295) from Meryl Gorge on PRM-35-22 - Reporting Nuclear Medicine Injection Extravasations as Medical Events ML20302A1392020-10-260Issue date: 26 October 2020 Title: Comment (277) from Dawn Cavins on PRM-35-22 - Reporting Nuclear Medicine Injection Extravasations as Medical Events ML20302A1372020-10-260Issue date: 26 October 2020 Title: Comment (275) from Glenn Bendall on PRM-35-22 - Reporting Nuclear Medicine Injection Extravasations as Medical Events ML20302A1432020-10-260Issue date: 26 October 2020 Title: Comment (281) from Ashley Thomas on PRM-35-22 - Reporting Nuclear Medicine Injection Extravasations as Medical Events ML20302A1492020-10-260Issue date: 26 October 2020 Title: Comment (286) from Dalton Cavins on PRM-35-22 - Reporting Nuclear Medicine Injection Extravasations as Medical Events ML20302A1512020-10-260Issue date: 26 October 2020 Title: Comment (288) from Lauren Shanbrun on PRM-35-22 - Reporting Nuclear Medicine Injection Extravasations as Medical Events ML20302A1442020-10-260Issue date: 26 October 2020 Title: Comment (282) from Anna Kerr on PRM-35-22 - Reporting Nuclear Medicine Injection Extravasations as Medical Events ML20302A1352020-10-260Issue date: 26 October 2020 Title: Comment (273) from Myla Cavins on PRM-35-22 - Reporting Nuclear Medicine Injection Extravasations as Medical Events ML20302A1362020-10-260Issue date: 26 October 2020 Title: Comment (274) from Kimberly Hogan on PRM-35-22 - Reporting Nuclear Medicine Injection Extravasations as Medical Events ML20302A1402020-10-260Issue date: 26 October 2020 Title: Comment (278) from Tammra Bryant on PRM-35-22 - Reporting Nuclear Medicine Injection Extravasations as Medical Events ML20302A1542020-10-260Issue date: 26 October 2020 Title: Comment (291) from Marjan Boerma on PRM-35-22 - Reporting Nuclear Medicine Injection Extravasations as Medical Events ML20302A1472020-10-260Issue date: 26 October 2020 Title: Comment (284) from Cecilia Pauley on PRM-35-22 - Reporting Nuclear Medicine Injection Extravasations as Medical Events ML20302A1382020-10-260Issue date: 26 October 2020 Title: Comment (276) from Jordan Case on PRM-35-22 - Reporting Nuclear Medicine Injection Extravasations as Medical Events ML20302A1412020-10-260Issue date: 26 October 2020 Title: Comment (279) from Heather Case on PRM-35-22 - Reporting Nuclear Medicine Injection Extravasations as Medical Events ML20301A8102020-10-240Issue date: 24 October 2020 Title: Comment (255) from Lisa Haskell on PRM-35-22 - Reporting Nuclear Medicine Injection Extravasations as Medical Events ML20297A5282020-10-230Issue date: 23 October 2020 Title: Comment (252) from Julie Taylor on on PRM-35-22 - Reporting Nuclear Medicine Injection Extravasations as Medical Events ML20297A3902020-10-230Issue date: 23 October 2020 Title: Comment (251) from Rupa Shah on PRM-35-22 - Reporting Nuclear Medicine Injection Extravasations as Medical Events ML20297A3652020-10-220Issue date: 22 October 2020 Title: Comment (243) from Mike Winter on PRM-35-22 - Reporting Nuclear Medicine Injection Extravasations as Medical Events ML20297A3872020-10-220Issue date: 22 October 2020 Title: Comment (248) from Joshua Reynolds on PRM-35-22 - Reporting Nuclear Medicine Injection Extravasations as Medical Events ML20296A5322020-10-210Issue date: 21 October 2020 Title: Comment (212) from Laura Peterson on PRM-35-22 - Reporting Nuclear Medicine Injection Extravasations as Medical Events ML20296A5902020-10-210Issue date: 21 October 2020 Title: Comment (225) from Guadalupe Medina on PRM-35-22 - Reporting Nuclear Medicine Injection Extravasations as Medical Events ML21034A5752020-10-210Issue date: 21 October 2020 Title: Comment (1828) of Jeff Ruch, on Behalf of Public Employees for Environmental Responsibility (Peer), Opposing Transfer of Very Low-Level Waste to Exempt Persons for Disposal ML20296A5272020-10-210Issue date: 21 October 2020 Title: Comment (207) from Laura Wotta on PRM-35-22 - Reporting Nuclear Medicine Injection Extravasations as Medical Events ML20296A5292020-10-210Issue date: 21 October 2020 Title: Comment (209) from Glenn Carney on PRM-35-22 - Reporting Nuclear Medicine Injection Extravasations as Medical Events ML20297A3462020-10-210Issue date: 21 October 2020 Title: Comment (230) from Elizabeth Farmer on PRM-35-22 - Reporting Nuclear Medicine Injection Extravasations as Medical Events ML20296A5882020-10-210Issue date: 21 October 2020 Title: Comment (223) from Chung Lee on PRM-35-22 - Reporting Nuclear Medicine Injection Extravasations as Medical Events ML20297A3452020-10-210Issue date: 21 October 2020 Title: Comment (229) from Lori Bachteler on PRM-35-22 - Reporting Nuclear Medicine Injection Extravasations as Medical Events ML20297A3432020-10-210Issue date: 21 October 2020 Title: Comment (227) from Quang Tran on PRM-35-22 - Reporting Nuclear Medicine Injection Extravasations as Medical Events ML20296A5812020-10-210Issue date: 21 October 2020 Title: Comment (216) from Benjamin Meyer on PRM-35-22 - Reporting Nuclear Medicine Injection Extravasations as Medical Events ML20296A5242020-10-210Issue date: 21 October 2020 Title: Comment (204) from Hung Dam on PRM-35-22 - Reporting Nuclear Medicine Injection Extravasations as Medical Events ML20297A3442020-10-210Issue date: 21 October 2020 Title: Comment (228) from Michael Connelly on PRM-35-22 - Reporting Nuclear Medicine Injection Extravasations as Medical Events ML20296A5872020-10-210Issue date: 21 October 2020 Title: Comment (222) from Edwin Goldstein on PRM-35-22 - Reporting Nuclear Medicine Injection Extravasations as Medical Events ML20297A3422020-10-210Issue date: 21 October 2020 Title: Comment (226) from Mike Roman on PRM-35-22 - Reporting Nuclear Medicine Injection Extravasations as Medical Events ML20296A5222020-10-200Issue date: 20 October 2020 Title: Comment (202) from Daniel Sullivan on PRM-35-22 - Reporting Nuclear Medicine Injection Extravasations as Medical Events ML20296A5212020-10-200Issue date: 20 October 2020 Title: Comment (201) from Anonymous on PRM-35-22 - Reporting Nuclear Medicine Injection Extravasations as Medical Events ML20296A5232020-10-200Issue date: 20 October 2020 Title: Comment (203) from Melissa Blake on PRM-35-22 - Reporting Nuclear Medicine Injection Extravasations as Medical Events ML20293A5032020-10-160Issue date: 16 October 2020 Title: Comment (150) from Heather Merchantz on PRM-35-22 - Reporting Nuclear Medicine Injection Extravasations as Medical Events ML20289A6122020-10-090Issue date: 9 October 2020 Title: Comment (113) from Adeara Bianchi on PRM-35-22 - Reporting Nuclear Medicine Injection Extravasations as Medical Events ML20289A5092020-10-090Issue date: 9 October 2020 Title: Comment (109) from Melissa Arturet on PRM-35-22 - Reporting Nuclear Medicine Injection Intravasations as Medical Events ML20289A6132020-10-090Issue date: 9 October 2020 Title: Comment (114) from Terri Crockett on PRM-35-22 - Reporting Nuclear Medicine Injection Extravasations as Medical Events ML20289A5022020-10-090Issue date: 9 October 2020 Title: Comment (102) from Michael Yu on PRM-35-22 - Reporting Nuclear Medicine Injection Intravasations as Medical Events ML20289A3942020-10-080Issue date: 8 October 2020 Title: Comment (092) from Lisa Patrick on PRM-35-22 - Reporting Nuclear Medicine Injection Intravasations as Medical Events ML20283A7452020-10-080Issue date: 8 October 2020 Title: Comment (039) from David Schuster on PRM-35-22 - Reporting Nuclear Medicine Injection Intravasations as Medical Events ML20289A5002020-10-080Issue date: 8 October 2020 Title: Comment (100) from Fatma Ahmed on PRM-35-22 - Reporting Nuclear Medicine Injection Intravasations as Medical Events ML20288A3612020-10-080Issue date: 8 October 2020 Title: Comment (059) from Michelle Flynn on PRM-35-22 - Reporting Nuclear Medicine Intravasations as Medical Events ML20288A3662020-10-080Issue date: 8 October 2020 Title: Comment (064) from Jeremy Heinrich on PRM-35-22 - Reporting Nuclear Medicine Intravasations as Medical Events ML20289A3962020-10-080Issue date: 8 October 2020 Title: Comment (094) from Caban Tarte on PRM-35-22 - Reporting Nuclear Medicine Injection Intravasations as Medical Events ML20288A3642020-10-080Issue date: 8 October 2020 Title: Comment (062) from Heather Lavinder on PRM-35-22 - Reporting Nuclear Medicine Intravasations as Medical Events ML20288A7752020-10-080Issue date: 8 October 2020 Title: Comment (087) from Kevin Beal on PRM-35-22 - Reporting Nuclear Medicine Injection Intravasations as Medical Events ML20288A3692020-10-080Issue date: 8 October 2020 Title: Comment (067) from David Knell on PRM-35-22 - Reporting Nuclear Medicine Intravasations as Medical Events ML20288A7632020-10-080Issue date: 8 October 2020 Title: Comment (076) from Maria Nolan on PRM-35-22 - Reporting Nuclear Medicine Injection Intravasations as Medical Events ML20283A7482020-10-080Issue date: 8 October 2020 Title: Comment (042) from Terry Roy on PRM-35-22 - Reporting Nuclear Medicine Injection Intravasations as Medical Events ML20288A3702020-10-080Issue date: 8 October 2020 Title: Comment (068) from Anne Schofield on PRM-35-22 - Reporting Nuclear Medicine Intravasations as Medical Events ML20288A7662020-10-080Issue date: 8 October 2020 Title: Comment (079) from Glowingrainbow Woods on PRM-35-22 - Reporting Nuclear Medicine Injection Intravasations as Medical Events ML20283A7582020-10-080Issue date: 8 October 2020 Title: Comment (052) from Lindsey Meadows on PRM-35-22 - Reporting Nuclear Medicine Injection Intravasations as Medical Events ML20283A7462020-10-080Issue date: 8 October 2020 Title: Comment (040) from Arthur Schnitzer on PRM-35-22 - Reporting Nuclear Medicine Injection Intravasations as Medical Events ML20288A3602020-10-080Issue date: 8 October 2020 Title: Comment (058) from Moira Pouls on PRM-35-22 - Reporting Nuclear Medicine Intravasations as Medical Events ML20283A7472020-10-080Issue date: 8 October 2020 Title: Comment (041) from Nancy Mcdonald on PRM-35-22 - Reporting Nuclear Medicine Injection Intravasations as Medical Events ML20283A7542020-10-080Issue date: 8 October 2020 Title: Comment (048) from Phyllis Tesluk on PRM-35-22 - Reporting Nuclear Medicine Injection Intravasations as Medical Events ML20288A7672020-10-080Issue date: 8 October 2020 Title: Comment (080) from Mohammad S. Qurashi on PRM-35-22 - Reporting Nuclear Medicine Injection Intravasations as Medical Events ML20283A7562020-10-080Issue date: 8 October 2020 Title: Comment (050) from James Gannon on PRM-35-22 - Reporting Nuclear Medicine Injection Intravasations as Medical Events ML20289A4022020-10-080Issue date: 8 October 2020 Title: Comment (099) from Luis Tamara on PRM-35-22 - Reporting Nuclear Medicine Injection Intravasations as Medical Events ML20288A7772020-10-080Issue date: 8 October 2020 Title: Comment (089) from Bill Decker on PRM-35-22 - Reporting Nuclear Medicine Injection Intravasations as Medical Events ML20283A7552020-10-080Issue date: 8 October 2020 Title: Comment (049) from Richard Chandler on PRM-35-22 - Reporting Nuclear Medicine Injection Intravasations as Medical Events ML20288A7652020-10-080Issue date: 8 October 2020 Title: Comment (078) from Sofiya Yovanic on PRM-35-22 - Reporting Nuclear Medicine Injection Intravasations as Medical Events ML20288A3672020-10-080Issue date: 8 October 2020 Title: Comment (065) from Togustine Nguyen on PRM-35-22 - Reporting Nuclear Medicine Intravasations as Medical Events ML20288A7722020-10-080Issue date: 8 October 2020 Title: Comment (085) from Fletcher Macomb on PRM-35-22 - Reporting Nuclear Medicine Injection Intravasations as Medical Events ML20288A3622020-10-080Issue date: 8 October 2020 Title: Comment (060) from Michelle Wanner on PRM-35-22 - Reporting Nuclear Medicine Intravasations as Medical Events ML20288A7762020-10-080Issue date: 8 October 2020 Title: Comment (088) from Mary Beth Farrell on PRM-35-22 - Reporting Nuclear Medicine Injection Intravasations as Medical Events ML20288A7622020-10-080Issue date: 8 October 2020 Title: Comment (075) from Mary Bardelli on PRM-35-22 - Reporting Nuclear Medicine Injection Intravasations as Medical Events ML20288A3572020-10-080Issue date: 8 October 2020 Title: Comment (055) from Scott Mckoin on PRM-35-22 - Reporting Nuclear Medicine Intravasations as Medical Events ML20288A7642020-10-080Issue date: 8 October 2020 Title: Comment (077) from Robert Flavell on PRM-35-22 - Reporting Nuclear Medicine Injection Intravasations as Medical Events ML20289A4002020-10-080Issue date: 8 October 2020 Title: Comment (097) from Jamie Casey on PRM-35-22 - Reporting Nuclear Medicine Injection Intravasations as Medical Events ML20283A7492020-10-080Issue date: 8 October 2020 Title: Comment (043) from Melissa Snody on PRM-35-22 - Reporting Nuclear Medicine Injection Intravasations as Medical Events ML20288A3712020-10-080Issue date: 8 October 2020 Title: Comment (069) from Michael Blandina on PRM-35-22 - Reporting Nuclear Medicine Intravasations as Medical Events ML20288A3752020-10-080Issue date: 8 October 2020 Title: Comment (073) from Susan Staten on PRM-35-22 - Reporting Nuclear Medicine Intravasations as Medical Events ML20282A4332020-10-060Issue date: 6 October 2020 Title: Comment (037) from Peter Borotto on PRM-35-22 - Reporting Nuclear Medicine Injection Extravasations as Medical Events 2025-09-11 |
Retrieved from "https://kanterella.com/w/index.php?title=NRC/SECY/RAS&oldid=607630"